Processing

Please wait...

Settings

Settings

Goto Application

1. WO2017140828 - BYL719 (ALPELISIB) FOR USE IN THE TREATMENT OF PIK3CA-RELATED OVERGROWTH SPECTRUM (PROS - CLOVES SYNDROME)

Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

[ EN ]

CLAIMS:

1. A method of treating PIK3CA-Related Overgrowth Spectrum (PROS) in a subject in need thereof comprising a step of administrating the subject with a therapeutically effective amount of BYL719.

2. The method of treating according to claim 1, wherein the PROS disorder is Congenital, Lipomatous, Overgrowth, Vascular Malformations, Epidermal Nevi and Spinal/Skeletal Anomalies and/or Scoliosis (CLOVES) syndrome.

3. The method of treating according to claim 1, wherein the PROS disorder is Klippel- Trenaunay syndrome.